FibroGen, Inc.（FGEN）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · FGEN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$6.44M	$29.62M	$46.80M	$140.73M	$235.31M
Cost of Revenue	$0.00M	$15.56M	$3.96M	$20.28M	$449.19M
Gross Profit	$0.00M	$14.06M	$42.84M	$120.45M	($213.88M)
Gross Margin %(computed)	0.00%	47.47%	91.53%	85.59%	-90.89%
Operating Expenses
R&D Expenses	$23.52M	$95.69M	$266.47M	$296.79M	$387.04M
G&A Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Total Operating Expenses	$51.23M	$164.48M	$365.56M	$421.48M	$74.65M
Operating Income	($45.90M)	($150.42M)	($322.72M)	($301.02M)	($288.53M)
Operating Margin %(computed)	-712.66%	-507.80%	-689.53%	-213.90%	-122.62%
Interest Income	$0.00M	$5.30M	$7.59M	$7.60M	—
Interest Expense	($8.76M)	$8.25M	$8.10M	$1.44M	$1.07M
Income Before Tax	($58.29M)	($153.37M)	($323.22M)	($293.30M)	($289.68M)
Income Tax Expense	($0.09M)	($0.27M)	($0.25M)	$0.36M	$0.35M
Net Income	$183.45M	($47.58M)	($284.23M)	($293.65M)	($290.02M)
Net Margin %(computed)	—	-160.63%	-607.29%	-208.66%	-123.25%
Per Share & EBITDA
EPS (Basic)	$45.37	$-0.48	$-2.92	$-3.15	$-3.15
Wtd Avg Shares	4.04M	100.04M	97.30M	93.58M	92.35M
EBITDA	($45.90M)	($142.43M)	($305.20M)	($282.82M)	($333.72M)
EBITDA Margin %(computed)	-712.66%	-480.83%	-652.09%	-200.96%	-141.82%